StressMarq is exhibiting at #FENS2024 in Vienna, Austria from June 25-29. Visit Booth 406 to meet our team and learn about our unique products for #Alzheimer 's, #Parkinson 's & neurodegenerative disease research!
Neurodegenerative protein constructs 🔬 bit.ly/3JuPQnd
U.S. Senate has passed the National Plan to End Parkinson's Act dedicated to ending #Parkinson 's disease. StressMarq is committed to supporting global research efforts with innovative reagents for Parkinson's research.🧠
See: bit.ly/2zo1saf & bit.ly/3UY65yF
StressMarq is proud to be rated by EcoVadis in sustainable business practices for the 2nd year in a row. This rigorous assessment process recognizes strong adherence to multiple #sustainability criteria.
Learn more about our commitment to sustainability🌱bit.ly/3WqdGbv
The May edition of 'What's New at StressMarq?' is now available! Check out our new biotinylated αSyn proteins & EcoVadis #sustainability rating, learn where we'll be exhibiting next, and see our featured product citations & blog posts.
Read it here! 📫 bit.ly/4bD59GG
Second succesfull day at the Society for Neuroscience (SfN) 2023 conference in Washington DC. Meetings on behalf of Sanbio BV with friends, colleagues and business partners like Cayman Chemical StressMarq OriGene and many more. #sfn23
The May edition of 'What's New at StressMarq?' is now available! Check out our new biotinylated αSyn proteins & EcoVadis #sustainability rating, learn where we'll be exhibiting next, and see our featured product citations & blog posts.
Read it here! 📫 bit.ly/4bD59GG
Chimeric antigen receptor macrophages (CAR-Ms) were able to reduce Aβ plaque load in #Alzheimer 's disease. StressMarq's #AmyloidBeta Oligomers, PFFs & Peptide (SPR-488, SPR-492 & SPR-485) played a key role in the research findings.
Read the new blog! 🧠 bit.ly/3wN8u6W
Post-Translational Modifications in #Alzheimers Disease: Diagnostic and Therapeutic Opportunities bit.ly/30MdhmS
New Product! StressMarq is pleased to launch #AlphaSynuclein Pre-formed Fibrils & Monomers: Biotinylated (C-Terminus) [SPR-508 & SPR-507] to facilitate monitoring & detection via streptavidin-based conjugates.
PFFs🔬 bit.ly/4aP9Dts | Monomers🔍 bit.ly/4aP9Dts